America in Transition Pages

Wednesday, July 20, 2016

FDA Panel Backs Psoriasis Drug With Caveats

(MedPage Today) -- Says suicide risk means brodalumab needs careful management

from MedPage Today Washington Watch http://ift.tt/29V32iX
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)